Skip to main content
Clinical Trials/NCT07034989
NCT07034989CompletedNot Applicable

Investigation of the Effectiveness of Telerehabilitation-Assisted Exercise Training in Individuals With Rheumatoid Arthritis-Associated Interstitial Lung Disease

Zülal TATAR1 site in 1 country10 target enrollmentStarted: March 5, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
Oxygen Saturation Measurement

Study Overview

Brief Summary

This study aimed to evaluate the effectiveness of asynchronously implemented telerehabilitation-supported respiratory physiotherapy and function-oriented trunk stabilization exercises, which have not been previously applied in individuals with RA-IAH.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosed with RA according to the 2010 EULAR/American College of Rheumatology diagnostic criteria
  • •Individuals with RA-associated Interstitial Lung Disease
  • •Individuals aged ≥18
  • •Agreeing to attend regular training throughout the study
  • •Having access to the internet and a computer

Exclusion Criteria

  • •10 pack-year smoking history
  • •Surgery or arthroscopic surgery within the last year
  • •Having any neurological or psychological disease that may prevent participation
  • •Patient's inability to comply with evaluation and education
  • •Having a psychiatric disease that will affect cooperation
  • •Individuals with serious functional limitations and cardiopulmonary and/or neurological disease unrelated to RA

Arms & Interventions

Control Group

No Intervention

Asynchronous exercise group

Active Comparator

Intervention: Exercise (Other)

Outcomes

Primary Outcomes

Oxygen Saturation Measurement

Time Frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

Secondary Outcomes

  • Modified Medical Research Council Dyspnea Scale(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Evaluation of respiratory muscle strength(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Modified Borg Scale(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Visual Analog Scale(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Leicester Cough Survey(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • St. George's Respiratory Survey(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Short Form-36 Quality of Life Survey(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Health Assessment Questionnaire(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)
  • Disease Activity(Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.)

Investigators

Sponsor
Zülal TATAR
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Zülal TATAR

Researcher

Pamukkale University

Study Sites (1)

Loading locations...

Similar Trials